Concepedia

A comparison of complete pathologic response rates following neoadjuvant chemotherapy among South African breast cancer patients with and without concurrent HIV infection

Sarah Nietz, Daniel S. O’Neil, Oluwatosin Ayeni, Wenlong Carl Chen, Maureen Joffe, Judith S. Jacobson, Alfred I. Neugut, Paul Ruff, Witness Mapanga, Ines Buccimazza,

Breast Cancer Research and Treatment · 2020 · 15 citations · 43 references

DOIFull text

Open access

Concepts

References

43

Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy

Carsten Denkert, Gϋnter von Minckwitz, Silvia Darb‐Esfahani et al. · The Lancet Oncology · 2017 · 2.1K citations

, , +14

Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

Sylvia Adams, Robert J. Gray, Sandra Demaria et al. · Journal of Clinical Oncology · 2014 · 1.3K citations · Full text

, , +17

Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients

Hager R. Ali, Elena Provenzano, Sarah‐Jane Dawson et al. · Annals of Oncology · 2014 · 790 citations · Full text

, , +14

Cancer Burden in the HIV-Infected Population in the United States

Meredith S. Shiels, Ruth M. Pfeiffer, Mitchell H. Gail et al. · JNCI Journal of the National Cancer Institute · 2011 · 778 citations · Full text

, , +17

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab

Roberto Salgado, Carsten Denkert, Christine Campbell et al. · JAMA Oncology · 2015 · 606 citations · Full text

, , +17